Dietary salt reduction in hypertension - What is the evidence and why is it still controversial?

被引:28
作者
Chrysant, GS [1 ]
Bakir, S [1 ]
Oparil, S [1 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
关键词
D O I
10.1016/S0033-0620(99)70007-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The link between sodium intake and hypertension remains controversial because of inconsistency between early epidemiologic studies, which showed a strong positive relationship between salt intake and blood pressure/incidence of hypertension, and more recent studies, which showed only modest decreases in blood pressure with sodium reduction, particularly in the normotensive population. In addition, there is clinical evidence that sodium is related to target organ damage such as left ventricular hypertrophy and renal disease. Although the evidence available linking sodium intake and blood pressure in the general population is weak, sodium reduction has been shown to be useful in hypertensive patients, particularly salt-sensitive patients. Whether dietary sodium reduction should be recommended for the general population remains questionable because of marginal benefit and the suggestion of possible deleterious effects on cardiovascular outcomes independent of blood pressure. This paper will review the definition and methods used in determining salt sensitivity, the evidence linking sodium intake and target organ damage, and modern studies of salt and blood pressure.
引用
收藏
页码:23 / 38
页数:16
相关论文
共 72 条
[1]   LOW URINARY SODIUM IS ASSOCIATED WITH GREATER RISK OF MYOCARDIAL-INFARCTION AMONG TREATED HYPERTENSIVE MEN [J].
ALDERMAN, MH ;
MADHAVAN, S ;
COHEN, H ;
SEALEY, JE ;
LARAGH, JH .
HYPERTENSION, 1995, 25 (06) :1144-1152
[2]   Dietary sodium intake and mortality: the national health and nutrition examination survey (NHANES I) [J].
Alderman, MH ;
Cohen, H ;
Madhavan, S .
LANCET, 1998, 351 (9105) :781-785
[3]   ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION [J].
ALDERMAN, MH ;
MADHAVAN, S ;
OOI, WL ;
COHEN, H ;
SEALEY, JE ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1098-1104
[4]  
Ambard L, 1904, Archives of General Medicine, V1, P520
[5]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[6]  
APPLEGATE WB, 1991, ANN EPIDEMIOL, V1, P455
[7]   RENIN PREDICTS DIASTOLIC BLOOD-PRESSURE RESPONSE TO NONPHARMACOLOGIC AND PHARMACOLOGICAL THERAPY [J].
BLAUFOX, MD ;
LEE, HB ;
DAVIS, B ;
OBERMAN, A ;
WASSERTHEILSMOLLER, S ;
LANGFORD, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (09) :1221-1225
[8]   RENIN AS A RISK FACTOR IN ESSENTIAL HYPERTENSION - MORE EVIDENCE [J].
BRUNNER, HR ;
SEALEY, JE ;
LARAGH, JH .
AMERICAN JOURNAL OF MEDICINE, 1973, 55 (03) :295-302
[9]   ESSENTIAL HYPERTENSION - RENIN AND ALDOSTERONE, HEART ATTACK AND STROKE [J].
BRUNNER, HR ;
BUHLER, FR ;
BARD, RH ;
BAER, L ;
GOODWIN, FT ;
NEWTON, MA ;
KRAKOFF, LR ;
LARAGH, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (09) :441-+
[10]   IMPLICATIONS OF SMALL REDUCTIONS IN DIASTOLIC BLOOD-PRESSURE FOR PRIMARY PREVENTION [J].
COOK, NR ;
COHEN, J ;
HEBERT, PR ;
TAYLOR, JO ;
HENNEKENS, CH .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (07) :701-709